18F-PSMA-1007 PET/CT检出前列腺癌弥漫性腹膜与网膜转移
Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT.
PubMed 文献 · Clin Nucl Med · 2022-01-01
本文报道一例80岁男性疑似前列腺癌转移患者,为再分期行18F-PSMA-1007 PET/CT检查。显像示前列腺、多发淋巴结及骨骼放射性摄取增高,并意外发现腹膜与网膜弥漫性放射性摄取极度增高,为前列腺癌极罕见转移部位。
要点
- 18F-PSMA-1007 PET/CT可用于前列腺癌再分期评估。
- 前列腺癌腹膜与网膜弥漫性转移极罕见但可被PSMA PET/CT检出。
- PSMA PET/CT示腹膜网膜弥漫摄取增高时需考虑前列腺癌转移。
核心结论
- 18F-PSMA-1007 PET/CT可检出前列腺癌罕见的弥漫性腹膜与网膜转移。
研究设计与样本
- 个案报道:一例80岁男性疑似前列腺癌转移患者行18F-PSMA-1007 PET/CT再分期。
主要发现
- PET/CT示前列腺、多发淋巴结及骨骼放射性摄取增高。
- 腹膜与网膜弥漫性放射性摄取极度增高,为前列腺癌极罕见转移部位。
临床怎么用
- 前列腺癌再分期行18F-PSMA-1007 PET/CT时,应关注腹膜与网膜弥漫性摄取增高,警惕罕见转移。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diffuse peritoneal and omental infiltration of prostate cancer detected by 18F-PSMA-1007 PET/CT was rarely reported. We report a case of an 80-year-old man who was suspected of prostate carcinoma metastasis and underwent 18F-PSMA-1007 PET/CT for restaging the disease. PET/CT imaging presented intense tracer uptake in the prostate gland, multiple lymph nodes, and bones. Interestingly, we found extremely increased radioactive uptake of diffuse peritoneum and omentum on 18F-PSMA-1007 PET/CT images, which are very rare metastatic sites for prostate cancer.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Ji X, Wang L, Lin J, et al. Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT. Clin Nucl Med. 2022. PMID: 34238806. doi:10.1097/RLU.0000000000003802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。